<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30844">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02705170</url>
  </required_header>
  <id_info>
    <org_study_id>260480</org_study_id>
    <nct_id>NCT02705170</nct_id>
  </id_info>
  <brief_title>IMR Assessment in Patients With New Diagnosis of Left Ventricle Dilatation</brief_title>
  <acronym>IMPAIRED</acronym>
  <official_title>Index of Microcirculatory Resistance (IMR) Assessment in Patients With New Diagnosis of Left Ventricular Dilatation Without Significant Coronary Artery Lesions: IMPAIRED Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish if, in patients with new diagnosis of left ventricular dilatation without
      documentation at the coronary artery angiography of significant coronary artery lesions,
      there is a damage of the coronary microcirculation at the IMR (index of microcirculatory
      resistance) assessment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Authors will enroll at the moment of coronary artery angiography patients without
      history of ischemic heart disease and new diagnosis (at transthoracic echocardiography) of
      left ventricular dilation.

      All patients will undergo coronary artery angiography. To be enrolled, it is necessary to
      have the absence of significant coronary artery stenosis (angiographic evaluation of the
      lesion &gt;40%) in all the vessels (main and side branch).

      The Authors will proceed to perform the evaluation of the index of microvascular resistance
      (IMR). The target vessel will be the left anterior descending artery.

      An intracoronary pressure/temperature sensor-tipped guidewire will be used. Thermodilution
      curves will be obtained during maximal hyperemia. The IMR will be calculated from the ratio
      of the mean distal coronary pressure at maximal hyperemia to the inverse of mean hyperemic
      transit time.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Index of microcirculatory resistance</measure>
    <time_frame>during coronary artery angiography</time_frame>
    <description>Measurement of IMR in the left anterior descending artery of patients with new diagnosis of left ventricular dilatation and no significant stenosis in epicardial coronary arteries</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiac death</measure>
    <time_frame>1-year</time_frame>
    <description>occurrence of cardiac death at 1 year</description>
  </secondary_outcome>
  <other_outcome>
    <measure>all-cause death</measure>
    <time_frame>1-year</time_frame>
    <description>occurrence of all-cause death at 1 year</description>
  </other_outcome>
  <other_outcome>
    <measure>heart failure</measure>
    <time_frame>1-year</time_frame>
    <description>occurrence of hospital admission for heart failure</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cardiomyopathies</condition>
  <condition>Microcirculation</condition>
  <condition>Microvessels</condition>
  <arm_group>
    <arm_group_label>left ventricle dilatation</arm_group_label>
    <description>The subjects of the investigation will be patients with recent diagnosis of unknown left ventricle dilatation. These subjects received coronary artery angiography as exam suggested by guidelines to discriminate the cause of left ventricle dilatation. In subjects without documentation of coronary artery lesions, the Authors will assess the index of microvascular resistance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>index of microvascular resistance</intervention_name>
    <description>Measurement of the index of microvascular resistance in the left anterior descending artery</description>
    <arm_group_label>left ventricle dilatation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing coronary artery angiography for new diagnosis of left ventricular
        dilatation (dilatative cardiomyopathy)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  new diagnosis of left ventricular dilation (dilatative cardiopathy)

          -  absence of significant (&gt;40%) coronary artery disease at coronary artery angiography

        Exclusion Criteria:

          -  history of ischemic heart disease

          -  history of significant valvular disease

          -  contraindication to hyperemic agent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Campo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria di Ferrara</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veronica Lodolini, BSc</last_name>
    <phone>0532/236450</phone>
    <phone_ext>+39</phone_ext>
    <email>veronica.lodolini@student.unife.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisa Mosele, BSc</last_name>
    <phone>0532/237227</phone>
    <phone_ext>+39</phone_ext>
    <email>elisa21mosele@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Ferrara</name>
      <address>
        <city>Cona</city>
        <state>Ferrara</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Tebaldi, MD</last_name>
      <phone>+390532236450</phone>
      <email>tblmtt@unife.it</email>
    </contact>
    <contact_backup>
      <last_name>Simone Biscaglia, MD</last_name>
      <phone>+390532236450</phone>
      <email>simone.biscaglia@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gianluca Campo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Tebaldi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simone Biscaglia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 8, 2017</lastchanged_date>
  <firstreceived_date>March 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Ferrara</investigator_affiliation>
    <investigator_full_name>Gianluca Campo</investigator_full_name>
    <investigator_title>Assistant Professor, Interventional Cardiologist</investigator_title>
  </responsible_party>
  <keyword>index of microvascular resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
